Association between diabetes status and breast cancer in US adults: findings from the US National Health and Nutrition Examination Survey

Objectives The aim of this study was to investigate the association between diabetes status and the risk of breast cancer among adult Americans, exploring the impact of BMI, age, and race on this relationship. Methods A cross-sectional analysis of 8,249 individuals from the National Health and Nutrition Examination Survey (NHANES) was conducted. Diabetes was categorized as type 2 diabetes and prediabetes, with both conditions diagnosed according to the ADA 2014 guidelines. The association between diabetes status and breast cancer risk was explored using multiple logistic regression analysis. Results Patients with diabetes had higher odds of breast cancer (OR: 1.51; 95% CI 1.00 to 2.28), Using the two-piecewise linear regression model, it was observed that there is a threshold effect in the risk of breast cancer occurrence at the age of 52 years. Specifically, the risk of breast cancer is relatively low before the age of 52 but increases significantly after this age. Conclusions This study identified a significant association between diabetes status and breast cancer risk among adult Americans. We also found a threshold effect in breast cancer occurrence at the age of 52. Age was significantly associated with breast cancer risk in both Non-Hispanic White and Non-Hispanic Black individuals. These findings underscore the importance of diabetes management, maintaining a healthy BMI, and age-related risk considerations in reducing breast cancer risk.

[1]  S. Maistro,et al.  Germline and Somatic mutations in postmenopausal breast cancer patients , 2021, Clinics.

[2]  Yun Wu,et al.  Impact of diabetes on promoting the growth of breast cancer , 2021, Cancer communications.

[3]  Wei Zhang,et al.  Femoral nerve block versus obturator nerve block for pain management after total knee replacement , 2020, Medicine.

[4]  Connie L. Engel,et al.  Paths to Prevention: California Breast Cancer Primary Prevention Plan , 2020 .

[5]  R. Hiatt,et al.  A Complex Systems Model of Breast Cancer Etiology: The Paradigm II Conceptual Model , 2020, Cancer Epidemiology, Biomarkers & Prevention.

[6]  B. Zimmerman,et al.  Diabetes and Metformin Association with Recurrence Score in a Large Oncotype Database of Breast Cancer Patients , 2020, Oncology.

[7]  P. Fasching,et al.  The genetic interplay between body mass index, breast size and breast cancer risk: a Mendelian randomization analysis , 2019, International journal of epidemiology.

[8]  E. Chowdhury,et al.  Oncogenic Signaling in Tumorigenesis and Applications of siRNA Nanotherapeutics in Breast Cancer , 2019, Cancers.

[9]  C. de la Fuente-Nunez,et al.  Natural and redesigned wasp venom peptides with selective antitumoral activity , 2018, Beilstein journal of organic chemistry.

[10]  Maciej Banach,et al.  Dietary food patterns and glucose/insulin homeostasis: a cross-sectional study involving 24,182 adult Americans , 2017, Lipids in Health and Disease.

[11]  P. Brennan,et al.  Breast Cancer in Australian Indigenous Women: Incidence, Mortality, and Risk Factors , 2017, Asian Pacific journal of cancer prevention : APJCP.

[12]  Mona F. Mahmoud,et al.  Studies on the antidiabetic activities of Momordica charantia fruit juice in streptozotocin-induced diabetic rats , 2017, Pharmaceutical biology.

[13]  2. Classification and Diagnosis of Diabetes , 2016, Diabetes Care.

[14]  M. Altbach,et al.  Phase II study of metformin for reduction of obesity-associated breast cancer risk: a randomized controlled trial protocol , 2016, BMC Cancer.

[15]  G. Georgiou,et al.  Serum irisin levels are lower in patients with breast cancer: association with disease diagnosis and tumor characteristics , 2015, BMC Cancer.

[16]  K. Freund,et al.  Disparities in breast cancer care and research: report from a Breast Cancer Research Foundation sponsored workshop, 9–10 October 2014 , 2015, npj Breast Cancer.

[17]  Zhong Wang,et al.  Convergence and divergence of genetic and modular networks between diabetes and breast cancer , 2015, Journal of cellular and molecular medicine.

[18]  C. Tseng.  Diabetes and breast cancer in Taiwanese women: a detection bias? , 2014, European journal of clinical investigation.

[19]  G. Hortobagyi,et al.  Obesity, diabetes, and survival outcomes in a large cohort of early-stage breast cancer patients. , 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

[20]  L. Arends,et al.  Systematic review and meta‐analysis of the association between diabetes mellitus and incidence and mortality in breast and colorectal cancer , 2013, The British journal of surgery.

[21]  S. Zhang,et al.  Clinical pathological characteristics and prognostic analysis of 1,013 breast cancer patients with diabetes , 2013, Breast Cancer Research and Treatment.

[22]  G. Eslick,et al.  Diabetes increases the risk of breast cancer: a meta-analysis. , 2012, Endocrine-related cancer.

[23]  Lester R Curtin,et al.  The National Health and Nutrition Examination Survey: Sample Design, 1999-2006. , 2012, Vital and health statistics. Series 2, Data evaluation and methods research.

[24]  D. Rose,et al.  Type 2 diabetes and obesity metabolic interactions: common factors for breast cancer risk and novel approaches to prevention and therapy. , 2012, Current diabetes reviews.

[25]  P. Iozzo,et al.  Pathophysiology of prediabetes. , 2011, The Medical clinics of North America.

[26]  L. Zeng,et al.  Hyperglycaemia confers resistance to chemotherapy on breast cancer cells: the role of fatty acid synthase. , 2010, Endocrine-related cancer.

[27]  T. Tai,et al.  Secular trend for mortality from breast cancer and the association between diabetes and breast cancer in Taiwan between 1995 and 2006 , 2009, Diabetologia.

[28]  B. Zinman,et al.  The impact of diabetes on survival following breast cancer , 2008, Breast Cancer Research and Treatment.

[29]  F. Schmidt.  Meta-Analysis , 2008 .

[30]  World Cancer Research Fund , 2007 .